CALCIPOTRIENE
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-05-06
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:37
Label at a glance#
ProductCALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2%
Active ingredientCALCIPOTRIENE, DICLOFENAC SODIUM, HYALURONATE SODIUM, NIACINAMIDE
Label structure4 sections
Label contents#
Full prescribing information#
ADVERSE REACTIONS SECTION
Active, inactive
NDC 72934-2030-2 CALCIPOTRIENE USP 0.005% / DICLOFENAC SODIUM USP 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE USP 2%. Cream 30 gm
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| CALCIPOTRIENE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| DICLOFENAC Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20190118 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-2030-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-26da-a910-e053-dadaa90a0b85 | CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-2030-2 | CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2% | 30 g in 1 BOTTLE, PUMP | CREAM | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-2030 | CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2% CREAM [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190507_883e1f59-2a7a-1ccd-e053-2995a90a1ef0.zip |
Products#
Every source-derived product name is available through these pages.
- CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2%
- CALCIPOTRIENE
- DICLOFENAC SODIUM
- DICLOFENAC
- HYALURONATE SODIUM
- HYALURONIC ACID
- NIACINAMIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-2030 | 72934-2030-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIPOTRIENE | 143NQ3779B | ACTIB |
| DICLOFENAC SODIUM | QTG126297Q | ACTIB |
| HYALURONATE SODIUM | YSE9PPT4TH | ACTIB |
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 883e1f59-2a7b-1ccd-e053-2995a90a1ef0 | 883e1f59-2a7a-1ccd-e053-2995a90a1ef0 | 2019-05-06 | Adverse reactions | 883e1f59-2a7b-1ccd-e053-2995a90a1ef0 883e1f59-2a7a-1ccd-e053-2995a90a1ef0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


